sacB-5-Fluoroorotic Acid-pyrE-Based Bidirectional Selection for Integration of Unmarked Alleles into the Chromosome of Rhodobacter capsulatus

von Yano, Takahiro, Sanders, Carsten, Catalano, John, Daldal, Fevzi
Veröffentlicht 2005

R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes

von Seymour, John F., Pfreundschuh, Michael, Trnĕný, Marek, Sehn, Laurie H., Catalano, John, Csinady, Eva, Moore, Nicola, Coiffier, Bertrand
Veröffentlicht 2014

Impact of maintenance therapy on subsequent treatment in patients with newly diagnosed multiple myeloma: use of “progression-free survival 2” as a clinical trial end-point

von Dimopoulos, Meletios A., Petrucci, Maria T., Foà, Robin, Catalano, John, Kropff, Martin, Terpos, Evangelos, Zhang, Jingshan, Grote, Lara, Jacques, Christian, Palumbo, Antonio
Veröffentlicht in Haematologica (2015)

Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Thalidomide Plus Dexamethasone Compared With Dexamethasone As Initial Therapy for Newly Diagnosed Multiple Myelom...

von Rajkumar, S. Vincent, Rosiñol, Laura, Hussein, Mohamad, Catalano, John, Jedrzejczak, Wieslaw, Lucy, Lela, Olesnyckyj, Marta, Yu, Zhinuan, Knight, Robert, Zeldis, Jerome B., Bladé, Joan
Veröffentlicht 2008

A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia

von Kipps, Thomas J., Eradat, Herbert, Grosicki, Sebastian, Catalano, John, Cosolo, Walter, Dyagil, Iryna S., Yalamanchili, Sreeni, Chai, Akiko, Sahasranaman, Srikumar, Punnoose, Elizabeth, Hurst, Deborah, Pylypenko, Halyna
Veröffentlicht in Leuk Lymphoma (2015)

The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study

von Tan, Peter, Tiong, Ing Soo, Fleming, Shaun, Pomilio, Giovanna, Cummings, Nik, Droogleever, Mark, McManus, Julie, Schwarer, Anthony, Catalano, John, Patil, Sushrut, Avery, Sharon, Spencer, Andrew, Wei, Andrew
Veröffentlicht in Oncotarget (2016)

Risk of Metachronous Colorectal Neoplasm After a Segmental Colectomy in Lynch Syndrome Patients According to Mismatch Repair Gene Status

von Quezada-Diaz, Felipe F, Hameed, Irbaz, von Mueffling, Alexa, Salo-Mullen, Erin E, Catalano, John D, Smith, J Joshua, Weiser, Martin R, Garcia-Aguilar, Julio, Stadler, Zsofia K, Guillem, Jose G
Veröffentlicht in J Am Coll Surg (2020)

Bortezomib-based antibody depletion for refractory autoimmune hematological diseases

von Ratnasingam, Sumita, Walker, Patricia A., Tran, Huy, Kaplan, Zane S., McFadyen, James D., Tran, Huyen, Teh, Tse-Chieh, Fleming, Shaun, Catalano, John V., Chunilal, Sanjeev D., Johnston, Anna, Opat, Stephen S., Shortt, Jake
Veröffentlicht in Blood Adv (2016)

SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis

von Mesa, Ruben A., Kiladjian, Jean-Jacques, Catalano, John V., Devos, Timothy, Egyed, Miklos, Hellmann, Andrzei, McLornan, Donal, Shimoda, Kazuya, Winton, Elliott F., Deng, Wei, Dubowy, Ronald L., Maltzman, Julia D., Cervantes, Francisco, Gotlib, Jason
Veröffentlicht in J Clin Oncol (2017)

Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemi...

von Iland, Harry, Bradstock, Ken, Seymour, John, Hertzberg, Mark, Grigg, Andrew, Taylor, Kerry, Catalano, John, Cannell, Paul, Horvath, Noemi, Deveridge, Sandra, Browett, Peter, Brighton, Tim, Chong, Li, Springall, Francisca, Ayling, Juliet, Catalano, Alberto, Supple, Shane, Collins, Marnie, Di Iulio, Juliana, Reynolds, John
Veröffentlicht 2012

Effect of Ruxolitinib Therapy on Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in COMFORT-I: A Randomized, Double-Blind, Placebo-Controlled Trial

von Mesa, Ruben A., Gotlib, Jason, Gupta, Vikas, Catalano, John V., Deininger, Michael W., Shields, Alan L., Miller, Carole B., Silver, Richard T., Talpaz, Moshe, Winton, Elliott F., Harvey, Jimmie H., Hare, Thomas, Erickson-Viitanen, Susan, Sun, William, Sandor, Victor, Levy, Richard S., Kantarjian, Hagop M., Verstovsek, Srdan
Veröffentlicht in J Clin Oncol (2013)

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

von Verstovsek, Srdan, Mesa, Ruben A., Gotlib, Jason, Gupta, Vikas, DiPersio, John F., Catalano, John V., Deininger, Michael W. N., Miller, Carole B., Silver, Richard T., Talpaz, Moshe, Winton, Elliott F., Harvey, Jimmie H., Arcasoy, Murat O., Hexner, Elizabeth O., Lyons, Roger M., Paquette, Ronald, Raza, Azra, Jones, Mark, Kornacki, Deanna, Sun, Kang, Kantarjian, Hagop
Veröffentlicht in J Hematol Oncol (2017)

The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis

von Verstovsek, Srdan, Mesa, Ruben A., Gotlib, Jason, Levy, Richard S., Gupta, Vikas, DiPersio, John F., Catalano, John V., Deininger, Michael, Miller, Carole, Silver, Richard T., Talpaz, Moshe, Winton, Elliott F., Harvey, Jimmie H., Arcasoy, Murat O., Hexner, Elizabeth, Lyons, Roger M., Paquette, Ronald, Raza, Azra, Vaddi, Kris, Erickson-Viitanen, Susan, Sun, William, Sandor, Victor, Kantarjian, Hagop M.
Veröffentlicht 2013

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I

von Verstovsek, Srdan, Mesa, Ruben A., Gotlib, Jason, Levy, Richard S., Gupta, Vikas, DiPersio, John F., Catalano, John V., Deininger, Michael W.N., Miller, Carole B., Silver, Richard T., Talpaz, Moshe, Winton, Elliott F., Harvey, Jimmie H., Arcasoy, Murat O., Hexner, Elizabeth O., Lyons, Roger M., Raza, Azra, Vaddi, Kris, Sun, William, Peng, Wei, Sandor, Victor, Kantarjian, Hagop
Veröffentlicht in Haematologica (2015)

A Double-Blind Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

von Verstovsek, Srdan, Mesa, Ruben A., Gotlib, Jason, Levy, Richard S., Gupta, Vikas, DiPersio, John F., Catalano, John V., Deininger, Michael, Miller, Carole, Silver, Richard T., Talpaz, Moshe, Winton, Elliott F., Harvey, Jimmie H., Arcasoy, Murat O., Hexner, Elizabeth, Lyons, Roger M., Paquette, Ronald, Raza, Azra, Vaddi, Kris, Erickson-Viitanen, Susan, Koumenis, Iphigenia L., Sun, William, Sandor, Victor, Kantarjian, Hagop M.
Veröffentlicht in N Engl J Med (2012)

Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I

von Verstovsek, Srdan, Mesa, Ruben A., Gotlib, Jason, Levy, Richard S., Gupta, Vikas, DiPersio, John F., Catalano, John V., Deininger, Michael W.N., Miller, Carole B., Silver, Richard T., Talpaz, Moshe, Winton, Elliott F., Harvey, Jimmie H., Arcasoy, Murat O., Hexner, Elizabeth O., Lyons, Roger M., Paquette, Ronald, Raza, Azra, Vaddi, Kris, Erickson-Viitanen, Susan, Sun, William, Sandor, Victor, Kantarjian, Hagop M.
Veröffentlicht 2013

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study

von Bachy, Emmanuel, Seymour, John F., Feugier, Pierre, Offner, Fritz, López-Guillermo, Armando, Belada, David, Xerri, Luc, Catalano, John V., Brice, Pauline, Lemonnier, François, Martin, Alejandro, Casasnovas, Olivier, Pedersen, Lars M., Dorvaux, Véronique, Simpson, David, Leppa, Sirpa, Gabarre, Jean, da Silva, Maria G., Glaisner, Sylvie, Ysebaert, Loic, Vekhoff, Anne, Intragumtornchai, Tanin, Le Gouill, Steven, Lister, Andrew, Estell, Jane A., Milone, Gustavo, Sonet, Anne, Farhi, Jonathan, Zeuner, Harald, Tilly, Hervé, Salles, Gilles
Veröffentlicht in J Clin Oncol (2019)

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies

von Mesa, Ruben A., Kiladjian, Jean-Jacques, Verstovsek, Srdan, Al-Ali, Haifa Kathrin, Gotlib, Jason, Gisslinger, Heinz, Levy, Richard, Siulnik, Andres, Gupta, Vikas, Khan, Mahmudul, DiPersio, John F., McQuitty, Mari, Catalano, John V., Hunter, Deborah S., Knoops, Laurent, Deininger, Michael, Cervantes, Francisco, Miller, Carole, Vannucchi, Alessandro M., Silver, Richard T., Barbui, Tiziano, Talpaz, Moshe, Barosi, Giovanni, Winton, Elliott F., Mendeson, Estella, Harvey, Jimmie H., Arcasoy, Murat O., Hexner, Elizabeth, Lyons, Roger M., Paquette, Ronald, Raza, Azra, Sun, William, Sandor, Victor, Kantarjian, Hagop M., Harrison, Claire
Veröffentlicht 2014

Lenalidomide maintenance for diffuse large B‐cell lymphoma patients responding to R‐CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study...

von Thieblemont, Catherine, Howlett, Susannah, Casasnovas, René‐Olivier, Mounier, Nicolas, Perrot, Aurore, Morschhauser, Franck, Fruchart, Christophe, Daguindau, Nicolas, van Eygen, Koen, Obéric, Lucie, Bouabdallah, Reda, Pica, Gian Matteo, Nicolas‐Virezelier, Emmanuelle, Abraham, Julie, Fitoussi, Olivier, Snauwaert, Sylvia, Eisenmann, Jean‐Claude, Lionne‐Huyghe, Pauline, Bron, Dominique, Tricot, Sabine, Deeren, Dries, Gonzalez, Hugo, Costello, Régis, Le Du, Katell, da Silva, Maria Gomes, Grosicki, Sebastian, Trotman, Judith, Catalano, John, Caballero, Dolores, Greil, Richard, Cohen, Amos M., Gaulard, Philippe, Roulin, Louise, Takeshita, Kenichi, Casadebaig, Marie‐Laure, Tilly, Hervé, Coiffier, Bertrand
Veröffentlicht in Br J Haematol (2019)

Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma

von Facon, Thierry, Dimopoulos, Meletios A., Dispenzieri, Angela, Catalano, John V., Belch, Andrew, Cavo, Michele, Pinto, Antonello, Weisel, Katja, Ludwig, Heinz, Bahlis, Nizar J., Banos, Anne, Tiab, Mourad, Delforge, Michel, Cavenagh, Jamie D., Geraldes, Catarina, Lee, Je-Jung, Chen, Christine, Oriol, Albert, De La Rubia, Javier, White, Darrell, Binder, Daniel, Lu, Jin, Anderson, Kenneth C., Moreau, Philippe, Attal, Michel, Perrot, Aurore, Arnulf, Bertrand, Qiu, Lugui, Roussel, Murielle, Boyle, Eileen, Manier, Salomon, Mohty, Mohamad, Avet-Loiseau, Herve, Leleu, Xavier, Ervin-Haynes, Annette, Chen, Guang, Houck, Vanessa, Benboubker, Lotfi, Hulin, Cyrille
Veröffentlicht in Blood (2018)